Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine 0.5% cream versus photodynamic therapy for actinic keratosis field treatment
RBR-8y3sj9Recruiting
- Sponsor
- UNESP Botucatu Medical School
- Start
- Mar 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in actinic keratosis (AK) and cutaneous field cancerization (CFC) comparing Topical colchicine 0.5% cream with Methyl aminolevulinate photodynamic therapy (2 arms). Started Mar 2016; status: recruiting.
02
Drugs
colchicinemethyl aminolevulinate
03
Conditions
actinic keratosis (AK)cutaneous field cancerization (CFC)
Beyond the preview
Go deeper on RBR-8y3sj9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8y3sj9.